rAAV production using HEK293 cell line and modified transfection medium

  • <<
  • >>

BlueskyReddit

As the race to deliver advanced gene therapies accelerates, AAV production must keep pace—with no room for inconsistency. This article dives into how high-performance cell culture media is unlocking new levels of reliability, scalability, and yield in AAV manufacturing.

Access Now

    Please fill out the information below to access the selected content. If you are already registered, and this information will be filled out for you.
  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • By submitting this form, you consent to Cell & Gene Therapy Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.